Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial - Nature
Source:Nature.com
In a phase 2 trial evaluating healthy donor fecal microbial transplantation plus either anti-PD-1 in patients with non-small cell lung cancer or anti-PD-1 and anti-CTLA-4 in patients with melanoma, encouraging efficacy was seen in both cohorts, with responses…
Related Articles
New evidence shows how discrimination shortens lives in Black communities - The Washington Post
Researchers linked higher inflammation levels to decades of stress, including discrimination and …
Deadly, drug-resistant fungus spreads in California. Here’s who is at risk - sacbee.com
California reported Candida auris outbreaks at health care facilities. Learn who’s most at risk for …
Opinion | The long-lasting effects of viruses — and the anti-vaccine movement - The Washington Post
For some people, a viral infection can have devastating long-term effects.
These patients saw what comes after death. Should we believe them? - The Washington Post
Researchers have developed a model to explain the science of near-death experiences. Others have …